The American Heart Association indicates ... The company acquired Affera Inc., which produces treatments for arrhythmias, for $904 million in 2022. Medtronic won European approval for the Affera ...

Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions. The Dublin-based medical technology ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medical technology giant Medtronic will purchase miniaturised ... s smallest ventricular assist device for the treatment of congestive heart failure, designed to reduce both surgical invasiveness ...

"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

Success of the treatments was measured by adding ... Newsnight found that he'd become chief medical officer of Medtronic Structural Heart. By Newsnight's count, around half of the investigators ...

There, physicians confirmed through standard treatment that the map Ramanathan and Jia created was correct. Accurate heart mapping is important in ... funds.The company also used $12 million from a ...

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

First double-blind randomised trial of its kind finds widely used ablation procedure significantly reduces atrial fibrillation burden and substantially improves symptoms and quality of life compared ...

Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...

Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.